Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
01:54 | Sona Nanotech Inc: Sona completes bacterial endotoxin test on nanorods | 3 | Stockwatch | ||
Do | Sona Nanotech Inc.: Sona Announces Successful Study Showing Absence of Endotoxins In Its Cancer Therapy Gold Nanorods Prior to First-in-human Clinical Trial | 398 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - May 15, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce the successful completion of bacterial endotoxin... ► Artikel lesen | |
07.05. | BioVaxys & Sona Nanotech Enter Research Collaboration | 3 | Contract Pharma | ||
07.05. | Sona Nanotech Inc.: BioVaxys and Sona Nanotech Enter Research Collaboration | 523 | Newsfile | Vancouver, British Columbia, and Halifax, Nova Scotia--(Newsfile Corp. - May 7, 2025) - BioVaxys Technology Corp. (CSE: BIOV) (FSE: 5LB) (OTCQB: BVAXF) ("BioVaxys") and Sona Nanotech Inc. (CSE: SONA)... ► Artikel lesen | |
07.05. | BioVaxys Technology Corp.: BioVaxys and Sona Nanotech Enter Research Collaboration | 715 | PR Newswire | VANCOUVER, BC and HALIFAX, NS, May 7, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys") and Sona Nanotech Inc.... ► Artikel lesen | |
SONA NANOTECH Aktie jetzt für 0€ handeln | |||||
01.05. | Sona Nanotech Inc: Sona Nanotech grants options to buy 2.13 million shares | 1 | Stockwatch | ||
01.05. | Sona Nanotech Inc.: Sona Nanotech Announces Annual Options Grants | 1.062 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - May 1, 2025) - Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the "Company" or "Sona") announces that it has granted 2,135,000 incentive stock options under... ► Artikel lesen | |
19.03. | Sona Nanotech Inc.: Sona Presents Additional Preclinical Data Demonstrating Repeated Ability Of Its Cancer Therapy To Inhibit Tumor Growth In Colorectal Cancer Model | 806 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - March 19, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to provide updated data confirming efficacy of its Targeted... ► Artikel lesen | |
06.03. | Sona Nanotech Inc. CEO David Regan to Present at the Investor Summit Virtual on March 11 | 431 | ACCESS Newswire | NEW YORK, NY / ACCESS Newswire / March 6, 2025 / David Regan, CEO of Sona Nanotech Inc. (OTCQB:SNANF)(CSE:SONA), will be presenting at this year's Investor Summit Virtual on March 11th at 11:30am ET.About... ► Artikel lesen | |
12.02. | Sona Nanotech Inc.: Sona Nanotech's Targeted Hyperthermia Therapy To Be Presented at the International 19th Canadian Melanoma Conference | 451 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - February 12, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce that its recently published findings from its... ► Artikel lesen | |
14.01. | Sona Nanotech Inc: Sona publishes THT cancer therapy efficacy studies | 1 | Stockwatch | ||
13.01. | Sona Nanotech Inc.: Sona Nanotech's THT Cancer Therapy Preclinical Efficacy Studies Published In Peer-Reviewed Scientific Journal | 483 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - January 13, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce that the now complete findings from our previously... ► Artikel lesen | |
12.12.24 | Sona Nanotech Inc: Sona releases results from preclinical study of GNRs | 4 | Stockwatch | ||
11.12.24 | Sona Nanotech Inc.: Sona Nanotech's THT Cancer Studies Demonstrates Strong Efficacy in Third Preclinical Study and Plans for First-in-human Early Feasibility Study | 575 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - December 11, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") announces results from its most recent preclinical study of its Targeted... ► Artikel lesen | |
07.11.24 | Sona Nanotech Inc.: Sona Nanotech to Showcase Its THT Cancer Therapy at NCL 20th Anniversary Symposium and Provides Corporate Update | 562 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - November 7, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce that its Chief Scientific Officer, Dr. Len Pagliaro... ► Artikel lesen | |
21.10.24 | Sona Nanotech Inc.: Sona Nanotech Issued Patent and Appoints New Board Member | 572 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - October 21, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce the issuance of U.S. Patent No. 12117447 by... ► Artikel lesen | |
09.10.24 | Sona Nanotech Inc.: Sona Nanotech Grants Options | 578 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - October 9, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona") is pleased to announce that it has granted 25,000 incentive stock... ► Artikel lesen | |
24.09.24 | Sona Nanotech Inc.: Sona Nanotech Closes Private Placement Financing to Raise $1,643,750 in Gross Proceeds | 766 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - September 24, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona") is pleased to announce that it has closed its non-brokered private... ► Artikel lesen | |
05.09.24 | Sona Nanotech Inc.: Sona Nanotech Closes Private Placement Financing to Raise $1,500,000 in Gross Proceeds and Announces Additional Financing | 870 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - September 5, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona") is pleased to announce that it has closed its non-brokered private... ► Artikel lesen | |
31.07.24 | Sona Nanotech Inc.: Sona Nanotech to Arrange Private Placement Financing | 734 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - July 31, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce that it plans to raise up to $1,500,000 through... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FORMYCON | 22,900 | -1,29 % | Formycon-Aktie: Kurs fällt ab (23,90 €) | An der deutschen Börse notiert das Wertpapier von Formycon derzeit ein wenig leichter. Der jüngste Kurs betrug 23,90 Euro. Für die Aktie von Formycon steht gegenwärtig ein Abschlag von 2,65 Prozent... ► Artikel lesen | |
OBDUCAT | 0,055 | +1,85 % | NGM MARKET NOTICE: #25-43 Information regarding the last day of trading in paid subscribed shares issued by Obducat AB | ||
SOLESENCE | 3,760 | 0,00 % | SOLESENCE, INC. - 10-Q, Quarterly Report | ||
ONTO INNOVATION | 87,50 | -0,57 % | Onto Innovation: Chancen und Risiken einer dynamischen Aktie | ||
VEECO INSTRUMENTS | 19,100 | +0,53 % | VEECO INSTRUMENTS INC - 8-K, Current Report | ||
KOPIN | 1,350 | -1,03 % | KOPIN CORP - 10-Q, Quarterly Report | ||
GAUZY | 8,720 | 0,00 % | Gauzy GAAP EPS of -$0.58, revenue of $22.4M | ||
GOMSPACE | 0,951 | +7,34 % | GOMSPACE GROUP AB: Annual general meeting held in GomSpace Group AB (publ) | ||
NANOFORM FINLAND | 0,942 | -1,57 % | Nanoform Finland Oyj: Resolutions of the Constitutive Meeting of the Board of Directors of Nanoform Finland Plc | Company release
Nanoform Finland Plc
April 15, 2025
14.10 Finnish time / 13.10 Swedish time
Resolutions of the Constitutive Meeting of the Board of Directors of Nanoform Finland Plc
Nanoform Finland... ► Artikel lesen | |
FENDX TECHNOLOGIES | 0,043 | -9,58 % | FendX Technologies Inc.: FendX Announces Share Issuance Pursuant to IP License Agreement | Oakville, Ontario--(Newsfile Corp. - May 5, 2025) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or "FendX"), a nanotechnology company developing surface protection... ► Artikel lesen | |
ACACIA RESEARCH | 3,200 | 0,00 % | ACACIA RESEARCH CORP - 10-Q, Quarterly Report | ||
NVE | 62,50 | +0,81 % | Dividendenbekanntmachungen (03.02.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACUITY BRANDS INC US00508Y1029 0,17 USD 0,1641 EUR AMERISERV FINANCIAL INC US03074A1025 0,03 USD 0,0289 EUR AON PLC IE00BLP1HW54 0... ► Artikel lesen | |
ADVANCE ZINCTEK | 0,434 | -0,46 % | ADVANCE ZINCTEK LIMITED: Business Update | ||
LEHNER INVESTMENTS | 0,035 | 0,00 % | EQS-Adhoc: LEHNER INVESTMENTS AG: Sonderprüfung gerichtlich angeordnet | EQS-Ad-hoc: LEHNER INVESTMENTS AG / Schlagwort(e): Rechtssache
LEHNER INVESTMENTS AG: Sonderprüfung gerichtlich angeordnet
04.04.2025 / 18:00 CET/CEST
Veröffentlichung einer Insiderinformation... ► Artikel lesen | |
NANOFOCUS | 1,180 | 0,00 % | NanoFocus schließt Kapitalerhöhung ab | Die NanoFocus AG hat die beschlossene Kapitalerhöhung gegen Sach- und Bareinlagen durchgeführt. Insgesamt wurden 6.021.664 neue Aktien zu je 1,00 Euro ausgegeben. Davon gingen 4.276.884 Aktien an die... ► Artikel lesen |